PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 31705883-8 2020 Comparisons of PLGF, sFLT-1 and sFLT-1/PLGF ratio in MoM values between the two groups of chronic hypertension and the controls were made by the ANOVA or the Kruskal-Wallis test. Molybdenum 53-56 placental growth factor Homo sapiens 39-43 31705883-9 2020 RESULTS: In the group of chronic hypertension that developed preeclampsia, compared to those that did not develop preeclampsia, there were significantly lower median concentrations of serum PLGF MoM (0.904, interquartile range (IQR) 0.771-1.052 vs. 0.948, IQR 0.814-1.093; p=0.014) and sFLT-1 MoM (0.895, IQR 0.760-1.033 vs 0.938, IQR 0.807-1.095; p=0.013) and they were both lower than in the normotensive controls (1.009, IQR 0.901-1.111 and 0.991, IQR 0.861-1.159, respectively; P<0.01 for both). Molybdenum 195-198 placental growth factor Homo sapiens 190-194 31589866-15 2019 In pregnancies with preterm PE, the mean MoM values of MAP and UtA-PI were significantly higher (MAP: 1.099 vs. 1.008; p<0.001; UtA-PI: 1.188 vs 1.063; p=0.006), and the mean PlGF MoM was significantly lower (0.760 vs. 1.100; p<0.001) than in women without PE. Molybdenum 41-44 placental growth factor Homo sapiens 178-182